Answers are grounded in this paper and cite their sources.
BACKGROUND & OBJECTIVE: and inhibits the signal transduction pathway of PI3K/Akt, MAPK, and activation of NFκB, which could be useful to treat overexpressed-HER-2 hepatocellular carcinoma (HCC). METHODS: ) dissolved in water, group3 (curcumin treated), and group 4 (curcumin and arsenic treated) received 10 to 20mg/5mL/kg for 60 days. Once experimental period was completed, liver samples were collected. The analysis of the gene expression was performed by real-time polymerase chain reaction (PCR) technique. CONCLUSION: According to the current study results, it could be concluded that curcumin has the inhibitory potential toward HER-2-overexpressed HCC.
No takes yet. Share an insight, caveat, or question.
Ahadi et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: